X0206 3 2020-10-08 0 0001680367 Shattuck Labs, Inc. STTK 0001827232 Pandite Arundathy N. C/O SHATTUCK LABS, INC. 1018 W. 11TH STREET, SUITE 100 AUSTIN TX 78703 0 1 0 0 Chief Medical Officer Common Stock 100303 D Stock Option (Right to Buy) 0.01 2027-12-21 Common Stock 5863 D Stock Option (Right to Buy) 2.95 2028-09-18 Common Stock 63705 D Stock Option (Right to Buy) 4.67 2030-08-05 Common Stock 82200 D Includes 16,789 restricted stock units, which will vest in equal monthly installments through July 24, 2021, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 5,863 shares of the Issuer's common stock, 527 of which have vested, with the remaining shares vesting in equal monthly installments through July 24, 2021, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 63,705 shares of the Issuer's common stock, 37,161 of which have vested, with the remaining shares vesting in equal monthly installments through May 15, 2022, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 82,200 shares of the Issuer's common stock, one quarter of which will vest on August 6, 2021, with the remaining three quarters vesting in equal monthly installments through August 6, 2024, subject to the Reporting Person's continued service to the Issuer. Exhibit 24 - Power of Attorney /s/ Erin Ator Thomson, Attorney-in-fact for Arundathy N. Pandite 2020-10-08